Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-dose Versus Standard-dose Remimazolam for Prevention of Emergence Agitation After Nasal Surgery Under Sevoflurane Anesthesia: A Randomized Double-blind Non-inferiority Trial

NCT07740655 is registered in ClinicalTrials.gov with Jeju National University School of Medicine as lead sponsor.

NCT NCT07740655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07740655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-dose Versus Standard-dose Remimazolam for Prevention of Emergence Agitation After Nasal Surgery Under Sevoflurane Anesthesia: A Randomized Double-blind Non-inferiority Trial
Lead sponsor
Jeju National University School of Medicine
Phase
Phase 4
Overall status
Not yet recruiting
Start date
July 24, 2026
Completion date
July 31, 2027
Enrollment
138 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

emergence agitation, general anesthesia, nasal surgical procedures